Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
21 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/21/3012724/0/en/Nacuity-Pharmaceuticals-Granted-U-S-FDA-Fast-Track-Designation-for-NPI-001-N-acetylcysteine-amide-Tablets-for-the-Treatment-of-Retinitis-Pigmentosa.html
30 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/30/2872335/0/en/Nacuity-Pharmaceuticals-Announces-First-Patients-Implanted-in-Final-Cohort-of-Phase-1-2-Clinical-Trial-Evaluating-NPI-002-Intravitreal-Implant-for-the-Delay-of-Cataract-Progression.html
16 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/16/2863683/0/en/Nacuity-Pharmaceuticals-Expands-Board-of-Directors-with-Appointment-of-Dr-Emmett-Cunningham-Jr.html
12 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/03/12/2844590/0/en/Arctic-Therapeutics-and-Nacuity-Pharmaceuticals-Announce-European-Medicines-Agency-Approval-to-Initiate-First-Clinical-Trial-of-AT-001-NPI-001-for-the-Treatment-of-HCCAA.html
14 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/14/2829109/0/en/Nacuity-Pharmaceuticals-Announces-Expansion-of-its-Business-Advisory-Board-with-Appointment-of-Rare-Disease-Advocate-Daniel-Feller.html
11 Jul 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/07/11/2702711/0/en/Nacuity-Pharmaceuticals-Advances-Phase-1-2-Clinical-Trial-Evaluating-NPI-002-Intravitreal-Implant-for-the-Delay-of-Cataract-Progression.html
ABOUT THIS PAGE